Human islet isolation and allotransplantation in 22 consecutive cases.

PubWeight™: 2.20‹?› | Rank: Top 2%

🔗 View Article (PMC 2967200)

Published in Transplantation on February 01, 1992

Authors

C Ricordi1, A G Tzakis, P B Carroll, Y J Zeng, H L Rilo, R Alejandro, A Shapiro, J J Fung, A J Demetris, D H Mintz

Author Affiliations

1: University of Pittsburgh, Transplant Institute, Pennsylvania 15213.

Articles citing this

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A (1999) 1.79

Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest (1996) 1.46

Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37

Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. Transplant Proc (1992) 1.01

Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99

Combined simultaneous kidney/bone marrow transplantation. Transplantation (1995) 0.98

An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc (1997) 0.94

The effect of prednisone on pancreatic islet autografts in dogs. Surgery (1993) 0.92

Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat (2007) 0.89

Insulin independence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal exenteration. Transplant Proc (1995) 0.88

Morphological changes of isolated rat pancreatic islets: a structural, ultrastructural and morphometric study. J Anat (2006) 0.88

The spectrum of action of new immunosuppressive drugs. Clin Exp Immunol (1992) 0.87

Osteogenic differentiation of human dental pulp stromal cells on 45S5 Bioglass® based scaffolds in vitro and in vivo. Tissue Eng Part A (2012) 0.82

Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol (1992) 0.81

Assessment of islet function following islet and pancreas transplantation. Curr Diab Rep (2006) 0.81

Investigating the Vascularization of Tissue-Engineered Bone Constructs Using Dental Pulp Cells and 45S5 Bioglass® Scaffolds. Tissue Eng Part A (2015) 0.81

Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc (1997) 0.80

Transplantation of cultured small bowel enterocytes. Gut (1993) 0.79

Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78

Assessing the effect of immunosuppression on engraftment of pancreatic islets. Transplantation (2013) 0.76

Glucose homeostasis is regulated by donor islets in xenografts. Transplant Proc (1992) 0.76

Diabetic heart dysfunction: is cell transplantation a potential therapy? Heart Fail Rev (2003) 0.76

A Review of Autologous Islet Transplantation. Cell Med (2013) 0.75

Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. Transplant Proc (1993) 0.75

Cellular transplantation and gene therapy. Clin Transplant (1993) 0.75

Successful islet allotransplantation in diabetic rats immunosuppressed with FK506: a functional and immunological study. Metabolism (1994) 0.75

Outcome of human islet isolation and allotransplantation in 20 consecutive cases. Diabetes Nutr Metab (1992) 0.75

Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. Transplantation (1993) 0.75

Functional evaluation of isolated islets from baboon pancreata. Transplant Proc (1995) 0.75

Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc (1992) 0.75

Treatment of diabetes mellitus. Diabetologia (1992) 0.75

Articles cited by this

Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63

Automated method for isolation of human pancreatic islets. Diabetes (1988) 8.23

Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Islet isolation assessment in man and large animals. Acta Diabetol Lat (1991) 2.89

Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57

Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc (1990) 2.40

Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 2.15

Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes (1989) 1.81

A method for isolation of islets of Langerhans from the human pancreas. Diabetes (1984) 1.60

Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med (1987) 1.58

Isolation of the elusive pig islet. Surgery (1990) 1.56

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania (1965-1976). Diabetes (1981) 1.44

Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest (1990) 1.40

Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients. Transplantation (1990) 1.39

Natural history of intrahepatic canine islet cell autografts. J Clin Invest (1986) 1.37

Developments in isolated pancreatic islet transplantation. Transplantation (1987) 1.30

Human islet transplantation in patients with type I diabetes. Transplant Proc (1989) 1.22

Epiploic flap: a new site for islet implantation in man. Horm Metab Res Suppl (1990) 1.12

Critical mass of purified islets that induce normoglycemia after implantation into dogs. Diabetes (1988) 1.10

Islet cell transplantation in type I diabetes mellitus. Transplant Proc (1987) 1.02

Combined liver and pancreatic islet transplantation in the rat. Transplantation (1983) 1.00

Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients. Surgery (1987) 0.97

Renal transplantation in diabetes. Clin Endocrinol Metab (1986) 0.96

Pancreas and islet transplantation. II. Clinical trials. Diabetologia (1981) 0.96

Isolation of viable islets of Langerhans from collagenase-perfused canine and human pancreata. Transplant Proc (1987) 0.94

Successful autotransplantation of isolated islets of Langerhans in the cynomolgus monkey. Br J Surg (1986) 0.93

Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function. Transplantation (1991) 0.92

Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85

Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Liver transplantation (1). N Engl J Med (1989) 4.53

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Liver transplantation (2). N Engl J Med (1989) 2.93

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Islet isolation assessment in man and large animals. Acta Diabetol Lat (1991) 2.89

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28

Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Hereditary haemorrhagic telangiectasia. Haemophilia (2008) 2.22

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis (1996) 2.12

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant (2012) 2.12

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09